Clinical trial underway for potential Long Covid treatment.
"A clinical trial is underway to assess the effectiveness and safety of Sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against COVID-19, as a potential treatment for Long Covid."
Source: https://silc.org/news/clinical-trial-underway-for-potential-long-covid-treatment/
GNU social JP is a social network, courtesy of GNU social JP管理人. It runs on GNU social, version 2.0.2-dev, available under the GNU Affero General Public License.
All GNU social JP content and data are available under the Creative Commons Attribution 3.0 license.